HomeQuestion

Do you ever consider maintenance therapy for patients with relapsed mantle cell lymphoma post CAR-T therapy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you manage a patient with primary CNS lymphoma who received R-MTX followed by autologous transplant with systemic relapse 5 years later for which R-Pola-CHP was given now followed by CNS relapse?

How would you approach adjusting nivo+AVD therapy for advanced Hodgkin lymphoma if a patient develops treatment limited immunotherapy toxicity?

How do you approach patient with CLL/SLL limited to the prostate?

Do you utilize ctDNA-based MRD testing after frontline chemotherapy for DLBCL?

Would you treat patient with early stage unfavorable classic Hodgkin lymphoma with 6 cycles instead of 4 cycles of Nivo-AVD to avoid mediastinal radiation in young female?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.